S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
Mullen Automotive Makes Deliveries; Short-Squeeze Possible
5 Hypergrowth Stocks to Buy Now (Ad)pixel
Schwab’s Drop This Week Could Be The Opening Of The Year (Again)
What is a Gold IRA, and is it a Viable Investment?
What To Do With Your Trades Today (Ad)pixel
Closing prices for crude oil, gold and other commodities
Walmart Shares Jump on Evercore Analyst Upgrade 
What To Do With Your Trades Today (Ad)pixel
Is Braze, Inc Ready To Rocket Higher? 
Can Frontline Maintain This Momentum?
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
Mullen Automotive Makes Deliveries; Short-Squeeze Possible
5 Hypergrowth Stocks to Buy Now (Ad)pixel
Schwab’s Drop This Week Could Be The Opening Of The Year (Again)
What is a Gold IRA, and is it a Viable Investment?
What To Do With Your Trades Today (Ad)pixel
Closing prices for crude oil, gold and other commodities
Walmart Shares Jump on Evercore Analyst Upgrade 
What To Do With Your Trades Today (Ad)pixel
Is Braze, Inc Ready To Rocket Higher? 
Can Frontline Maintain This Momentum?
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
Mullen Automotive Makes Deliveries; Short-Squeeze Possible
5 Hypergrowth Stocks to Buy Now (Ad)pixel
Schwab’s Drop This Week Could Be The Opening Of The Year (Again)
What is a Gold IRA, and is it a Viable Investment?
What To Do With Your Trades Today (Ad)pixel
Closing prices for crude oil, gold and other commodities
Walmart Shares Jump on Evercore Analyst Upgrade 
What To Do With Your Trades Today (Ad)pixel
Is Braze, Inc Ready To Rocket Higher? 
Can Frontline Maintain This Momentum?
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
Mullen Automotive Makes Deliveries; Short-Squeeze Possible
5 Hypergrowth Stocks to Buy Now (Ad)pixel
Schwab’s Drop This Week Could Be The Opening Of The Year (Again)
What is a Gold IRA, and is it a Viable Investment?
What To Do With Your Trades Today (Ad)pixel
Closing prices for crude oil, gold and other commodities
Walmart Shares Jump on Evercore Analyst Upgrade 
What To Do With Your Trades Today (Ad)pixel
Is Braze, Inc Ready To Rocket Higher? 
Can Frontline Maintain This Momentum?
NASDAQ:SNCE

Science 37 - SNCE Price Target & Analyst Ratings

$0.28
+0.02 (+7.65%)
(As of 03/31/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.26
$0.29
50-Day Range
$0.22
$0.62
52-Week Range
$0.19
$5.98
Volume
218,585 shs
Average Volume
1.54 million shs
Market Capitalization
$32.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.50

Science 37 Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Moderate Buy
Based on 5 Analyst Ratings

Consensus Analyst Price Target

$3.50
1,142.90% Upside
High Prediction$7.00
Average Prediction$3.50
Low Prediction$1.00
TypeCurrent
4/1/22 to 4/1/23
1 Month Ago
3/2/22 to 3/2/23
3 Months Ago
1/1/22 to 1/1/23
1 Year Ago
4/1/21 to 4/1/22
Consensus Rating
Moderate Buy
Moderate Buy
Moderate Buy
Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
4 Buy rating(s)
4 Buy rating(s)
4 Buy rating(s)
4 Buy rating(s)
Hold
1 Hold rating(s)
1 Hold rating(s)
1 Hold rating(s)
0 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$3.50$3.75$3.75$16.33
Predicted Upside1,142.90% Upside103.00% Upside103.00% Upside39.18% Upside
Get Science 37 Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for SNCE and its competitors with MarketBeat's FREE daily newsletter.

SNCE Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

SNCE Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Science 37 Stock vs. The Competition

TypeScience 37Medical CompaniesS&P 500
Consensus Rating Score
2.80
2.64
2.47
Consensus RatingModerate BuyBuyHold
Predicted Upside1,142.90% Upside1,994.54% Upside98.15% Upside
News Sentiment RatingNeutral News
Positive News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
3/7/2023Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$2.00 ➝ $1.00+265.09%
11/14/2022William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Smock
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform
11/14/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform$7.00 ➝ $3.00+252.94%
8/15/2022Craig Hallum
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$7.00+244.83%
11/16/2021Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$15.00 ➝ $20.00+41.84%
(Data available from 4/1/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












SNCE Price Target - Frequently Asked Questions

What is Science 37's consensus rating and price target?

According to the issued ratings of 5 analysts in the last year, the consensus rating for Science 37 stock is Moderate Buy based on the current 1 hold rating and 4 buy ratings for SNCE. The average twelve-month price prediction for Science 37 is $3.50 with a high price target of $7.00 and a low price target of $1.00. Learn more on SNCE's analyst rating history.

Do Wall Street analysts like Science 37 more than its competitors?

Analysts like Science 37 more than other Medical companies. The consensus rating for Science 37 is Moderate Buy while the average consensus rating for medical companies is Buy. Learn more on how SNCE compares to other companies.

Does Science 37's stock price have much upside?

According to analysts, Science 37's stock has a predicted upside of 175.69% based on their 12-month price targets.

What analysts cover Science 37?

Science 37 has been rated by Robert W. Baird in the past 90 days.


Stock Ratings Reports and Tools

This page (NASDAQ:SNCE) was last updated on 4/1/2023 by MarketBeat.com Staff